Head of IR Thomas Kudsk Larsen explains the multi-layered story behind the firm’s award-winning IR team
At a glance
Runner-up
Ranking at number two in this year’s IR Magazine Euro Top 100, the Anglo-Swedish AstraZeneca has ostensibly reaped the benefits of its IR efforts, which included a full team overhaul, newly improved IR literature and an emphasis on sell-side relationships.
Block building
Building the IR ‘house’, head of IR Thomas Kudsk Larsen has focused his outreach on US institutions, marketing the equity story of ‘a traditional growing
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
Andrew Holt
Reporter
